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The review by Gece [1] on the potential which chemotherapeutic agents may have as corrosion 
inhibitors is comprehensive in its coverage of the protective effects afforded by such agents. 
However, the author attempts within the first paragraph to dismiss the possibility that 
chemotherapeutic agents may have what he refers to as ‘negative impacts’ on the environment. 
The source of this reassurance is a single MSc thesis.  It is of course perfectly acceptable to cite 
an MSc thesis in such a context, but one wonders why the author is content to limit himself to 
just one source when there is in fact a vast amount of literature that has been published in the 
form of far more readily accessible journal articles on this very topic. To mention just one 
example, evidence has recently been provided of the persistence of antibiotic residues in river 
sediments for periods of up to 40 years which must at the very least raise concerns about the 
likelihood of effects on aquatic organisms [2].  
Antibiotics constitute the largest single class of drugs mentioned in the review, but Gece only 
considers their effects on pathogenic bacteria in total isolation to any anti-corrosive properties 
that antibiotics may possess. This is a serious oversight, as any use of antibiotics in environments 
where bacteria may be present increases the chances of selection for resistant organisms. Such 
organisms will not only transmit this resistance to their descendants but may also possibly 
transmit it via lateral or horizontal gene transfer to other species [3]. This is precisely the 
mechanism by which any particular antibiotic gradually become ineffective. For example, until 
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recently vancomycin was the antibiotic of last resort against methicillin resistant Staphylococcus 
aureus (MRSA) but accounts have appeared pointing to the emergence of vancomycin-resistant 
MRSA [4]. The use of this particular antibiotic outside of clinical applications would therefore 
serve to decrease the time-scale by which it would become completely ineffective against MRSA. 
This should be of universal concern as it is widely acknowledged that the ‘discovery pipeline’ for 
new antibiotics is showing alarming signs of running dry [5]. 
It is worth considering in slightly more detail how resistant bacteria could be selected for in the 
context of corrosion inhibition applications. Firstly, exposure of micro-organisms to antibiotics 
intended as corrosion inhibitors would be virtually impossible to prevent as micro-organisms are 
present in all human environments. Bacteria are to be found in association with dust particles 
that may readily become suspended in air and then go on to become widely distributed within 
buildings of all types. Some bacteria are even able to survive long exposures on the surfaces of 
metals [6].  Although there is no evidence of work having been conducted on the biostatic or 
biocidal properties of antibiotics that have been adsorbed onto metal surfaces, it is known, for 
example, that the antibiotic vancomycin is able to exert anti-bacterial activity even when 
adsorbed onto the surface of solid oxides [7]. All of which suggests that selection for antibiotic 
resistance could well be operating in parallel to the prevention of corrosion.  
Antibiotic solutions remaining after anti-corrosion treatments had been applied would of course 
need to be disposed of and would thereby contribute to the complement of antibiotics that find 
their way into the sewers as a result of purely clinical applications. Antibiotics have been detected 
in the outflows from sewage treatment works as well as in environments such as river sediments 
which were mentioned above. Whilst their concentration in such environments may be very low, 
they may still be capable of exerting effects on other micro-organisms present in those 
environments as is explained below.  
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In the last few years a new function has come to be associated with antibiotics: at concentrations 
considerably below their minimum inhibitory concentration (MIC) they are able to modulate 
gene expression in a wide range of micro-organisms without exerting any lethal effects 
whatsoever, and under these conditions are viewed rather as ‘signalling’ molecules than as 
antibiotics [8]. The consequences of this signalling range from activating virulence genes to 
initiating biofilm formation.  The concentration of individual antibiotics found in the 
environment will be considerably below those at which such effects are induced. However, 
environments such as estuarine sediments might contain residues of scores of pharmaceutically 
active compounds, and it is not impossible, but by no means proven, that they could exert a 
cumulative signalling effect on environmental organisms. All of these phenomenon merit further 
investigation – research which moreover should not be restricted solely to antibiotics, but which 
should encompass all the classes of chemotherapeutic agents mentioned by Gece.  
The prevention of corrosion is, it goes without saying, of enormous economic importance. 
However, whether this should be achieved at the cost of speeding up the development of 
antibiotic resistance is, I would suggest, too high a price to pay.   
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